DHAKA, Aug 4, 2025 (BSS) - The interim government approved a revised maximum retail price (MRP) list for 10 types of coronary stents in a move aimed at ensuring greater affordability and accessibility for cardiac patients across the country.

The Health Services Division under the Ministry of Health and Family Welfare issued a circular today, revising the prices of coronary stents manufactured by renowned international companies including Abbott, Boston Scientific and Medtronic.

Signed by Senior Assistant Secretary Mohammad Mozammel Hossain, the circular said the decision was based on recommendations from the National Committee on Essential Drugs and Medical Devices Pricing.

According to the directive, the new prices will be applicable for hospital procurement and patient billing, and have been adjusted in line with comparative market rates in India, reflecting substantial reductions.

The approved retail prices are: Resolute Onyx (Medtronic) - Tk 90,000; Promus Elite (Boston Scientific) - Tk 72,000; Promus Premier (Boston Scientific) - Tk 70,000; Synergy (Boston Scientific) - Tk 90,000; Synergy Shield (Boston Scientific) - Tk 90,000; Synergy XD (Boston Scientific) - Tk 1,00,000; Xience Prime (Abbott) - Tk 66,000; Xience Alpine (Abbott) - Tk 90,000; Xience Sierra (Abbott) - Tk 90,000 and Onyx Trucor (Medtronic) - Tk 50,000.

Hospitals have been instructed to follow the new pricing during procurement and billing, while suppliers are allowed a maximum 5% supply margin over the approved prices.

The directive further instructed all relevant hospital authorities to maintain proper documentation, including invoices and procurement data and submit them during audits to ensure transparency in implementation.